XORI Corporation
Latest round
- Series A
Last raised
- Jun 2009
Total raised
- $4.4M
Investors
- 7
About XORI Corporation
Based in Seattle, US, and founded in 2009, XORI Corporation is a biotechnology firm engaged in the development of a monoclonal antibody discovery and development platform. The company was founded by Dr. Nancy Maizels, the director of the Molecular Medicine programme and a professor in the Immunology and Biochemistry Departments at the University of Washington. The company’s primary focus is the invention of a technology dedicated to the discovery and development of monoclonal antibodies (MAbs), and potential products developed with this technology are mainly for infectious diseases, immune disorders and cancer therapy. The technology imitates the natural maturation and selection of antibodies with an expanded diversity repertoire, which can lead to the rapid generation of therapeutics against difficult disease targets.
Who invested in XORI Corporation
7 investors across 2 rounds
See all investors in XORI Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about XORI Corporation
Who invested in XORI Corporation?
XORI Corporation has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has XORI Corporation raised?
XORI Corporation has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did XORI Corporation last raise money?
XORI Corporation's most recent round on record is a Series A, in Jun 2009.
What does XORI Corporation do?
Based in Seattle, US, and founded in 2009, XORI Corporation is a biotechnology firm engaged in the development of a monoclonal antibody discovery and development platform.
Where is XORI Corporation headquartered?
XORI Corporation is headquartered in Seattle, US.
Which VCs invest in companies like XORI Corporation?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at XORI Corporation's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like XORI Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.